Navigation Links
Vasomedical to Report Second Quarter 2013 Results on August 13, 2013
Date:8/6/2013

WESTBURY, N.Y., Aug. 6, 2013 /PRNewswire/ -- Vasomedical, Inc. (OTC BB: VASO), announced today that it will release its financial results for the three months ended June 30, 2013 on Tuesday, August 13, 2013.

The Company will host a conference call the following day on Wednesday, August 14th at 11:00 a.m. ET featuring remarks by Jun Ma, Ph.D., President and CEO of Vasomedical, and Michael Beecher, Chief Financial Officer of Vasomedical. To dial into the conference call, please dial 1-866-393-1344 from the U.S. or 1-631-291-4669 internationally. All dial-in participants must use the following code to access the call: 26595138. Please call at least five minutes before the scheduled start time. The conference call will also be available via webcast and can be accessed through the Investor Relations section of Vasomedical's website, www.vasomedical.com, and www.kcsa.com. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.

A replay of the conference call will be available approximately two hours after completion of the live conference call at www.vasomedical.com or www.kcsa.com. To access the dial-in replay of the call, which will be available until September 16, 2013, please dial 1-855-859-2056 or 1-404-537-3406. All dial-in participants must use the following code to access the call: 26595138.

About Vasomedical
Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products.  The Company's main proprietary products are EECP® Therapy systems, the gold standard of ECP treatment. The Company operates through three wholly owned subsidiaries: VasoSolutions, Vasomedical Global and VasoHealthcare. VasoSolutions manages and coordinates the design, manufacture and sales of EECP® Therapy systems, and other medical equipment operations; Vasomedical Global operates the Company's China-based subsidiaries; and VasoHealthcare is the operating subsidiary for the exclusive sales representation of GE Healthcare diagnostic imaging products in certain market segments. Additional information is available on the Company's website at www.vasomedical.com.

Investor Contacts:
Todd Fromer / Garth Russell
KCSA Strategic Communications
212-896-1215 / 212-896-1250
tfromer@kcsa.com / grussell@kcsa.com  


'/>"/>
SOURCE Vasomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference
2. Vasomedical Announces Financial Results for the First Quarter of 2013
3. Vasomedical to Report First Quarter 2013 Results on May 15, 2013
4. Randy Hill Appointed to Vasomedical Board of Directors
5. Vasomedical Announces Share Repurchase Program of up to $1.5 Million in Common Stock
6. Vasomedical Announces Financial Results for the Fourth Quarter and Year Ended 2012
7. Vasomedical to Report Fourth Quarter and Year End 2012 Results on April 1, 2013
8. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
10. The International EECP Therapists Association and Vasomedical Announce Second Annual EECP Therapy Week
11. Vasomedical Common Stock Commences Trading on the OTCBB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... , January 16, 2017 Bill is ... number of general management and leadership positions with global medical device ... a strong track record of launching new products and building successful ... , Africa and North ... ...
(Date:1/16/2017)... , Jan. 16, 2017 CBDRx, the ... large amounts of phyto-nutrient rich hemp extract to Veteran,s ... donation of their proprietary hemp extract to Veteran,s groups ... the best hemp company in the world and through ... most nutritious, full spectrum phyto-nutrient rich hemp extract available. ...
(Date:1/13/2017)... 13, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: ... Corporate Finance and Investment Banking at Eli Lilly & Company, ... Mr. Bott brings over 28 years of senior financial and ... ... has established a significant leadership position in financial and ...
Breaking Medicine Technology:
(Date:1/15/2017)... ... 2017 , ... "On Tour is a music themed slideshow production package which ... Austin - CEO of Pixel Film Studios. , On Tour’s new slide presets ... animation of their slideshows. Place each slide on top of another slide or piece ...
(Date:1/15/2017)... ... January 14, 2017 , ... Wondering where to go this ... straight to your door for a romantic, lobster feast in the comfort of your ... Valentine's Day. The dinners will be featured until February 15th, 2017. , Romantic ...
(Date:1/15/2017)... , ... January 15, 2017 , ... ... in Montclair, NJ is pleased to announce that it will be assisting HackensackUMC ... in Montclair and Glen Ridge townships, servicing all surrounding towns. The firm will ...
(Date:1/14/2017)... CA (PRWEB) , ... January 13, 2017 , ... ... on Body and Soul, incorporating a magnesium-rich Mediterranean diet may lower the risk ... Café and Lounge notes that the many health and wellness benefits linked to ...
(Date:1/14/2017)... ... January 14, 2017 , ... "TransFreeze Volume 3 is a self animating masking transition ... in Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... freeze frame transition from one clip to the next. , To use “Cut-Out ...
Breaking Medicine News(10 mins):